Radiolabeling of Cramoll 1,4: Evaluation of the Biodistribution by Ferreira de Carvalho Patricio, Beatriz et al.
Hindawi Publishing Corporation
International Journal of Peptides
Volume 2011, Article ID 945397, 3 pages
doi:10.1155/2011/945397
Research Article
Radiolabeling of Cramoll 1,4: Evaluation of the Biodistribution
Beatriz Ferreirade Carvalho Patricio,1 MariaHelenaMadrugaLima-Ribeiro,2
Maria Tereza dos Santos Correia,3 AnaMariados Anjos Carneiro-Le˜ ao,3
Marta de SouzaAlbernaz,1 Thiago Barboza,1 SergioAugustoLopes deSouza,4
andRalph Santos-Oliveira1
1Laboratory of Nanoradiopharmaceuticals, Academical Hospital Clementino Fraga Filho, 21941-913 Rio de Janeiro, RJ, Brazil
2Department of Morphological and Biochemical Analysis, Rural University of Pernambuco, 52171-900 Recife, PE, Brazil
3Department of Biochemistry, Federal University of Pernambuco, 52171-900 Recife, PE, Brazil
4Departamento de Radiologia, Hospital Universit´ ario Clementino Fraga Filho Laborat´ orio de Marcac ¸˜ ao de C´ elulas e Mol´ eculas,
Universidade Federal do Rio de Janeiro, 21941-901 Rio de Janeiro, RJ, Brazil
Correspondence should be addressed to Ralph Santos-Oliveira, uﬃsta@gmail.com
Received 11 November 2010; Accepted 4 April 2011
Academic Editor: Tzi-Bunb Ng
Copyright © 2011 Beatriz Ferreira de Carvalho Patricio et al. This is an open access article distributed under the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.
The cramoll 1,4 is a well-studied lectin. However, few studies about its biodistribution have been done before. In this study, we
radiolabeled the cramol 1,4 with Tc-99m and analyzed the biodistribution. The results showed that the cramol has an abnormal
uptake by the bowel with reﬂections on its clearance mechanism.
1.Introduction
Lectinsareproteinsfrequentlyfoundincellularsurfacesorin
intracellular particles [1]. They possess binding sites speciﬁc
to carbohydrates and have the capacity to interact with mol-
ecules of biological ﬂuids and those present in cellular sur-
faces [2]. Lectins can substitute natural linkers and activate
cellular responses through diﬀerent roads of intracellular
signalling or endocytosis of formed compounds [3, 4]. The
therapeutic use of lectins in wound healing process is still
scarcely studied.
Camaratu or camaratuba bean (Cratylia mollis)i sf o r a g e
of the Northeast Semi-Arid Region from Brazil. Molecular
forms of C. mollis seed lectin (Cramoll 1, Cramoll 2, Cram-
oll 3, and Cramoll 4) have been highly puriﬁed and char-
acterized (de Souza et al., 2003) [2, 5]. Cramoll 1, Cramoll
2, and Cramoll 4 speciﬁcally bind glucose/mannose, while
Cramoll 3 is a galactose-speciﬁc glycoprotein. Preparations
containing isoforms (Cramoll 1,4) and isolectins (Cramoll
1,2,3), as well as Cramoll 1, have been studied in structural
analyses and for the most several biotechnological applica-
tions (de Souza et al., 2003) [6–12].
The use of nuclear technique for the evaluation of bio-
molecules and medicines although old is not widely used
even nowadays. Since the discovery of the element Techne-
tium, in 1947, it has been used for many purposes. Among
the various uses, the labeling process for molecules is the
most well established. Scintigraphy imaging provides a di-
mensional method for exactly locating gamma emitters
in a noninvasive procedure under in vivo conditions. For
the characterization of drugs, and biomolecules, molecular
imaging techniques are extremely helpful to follow biodistri-
bution in experimental animal studies [13]. In this study, the
isolectins Cramol 1,4 were radiolabeled with Tc-99m for the
evaluation of the biodistribution and in order to forecast a
possible use as radiopharmaceutical in healing process.
2. Methods
2.1. Chromatography. T h el a b e l i n gp r o c e s s e sw e r em a d eu s -
ing 150µL of cramol (isoform 1,4) solution incubated with
stannous chloride (SnCl2) solutions (80µL/mL) (Sigma-
Aldrich) for 20 minutes at room temperature. Then, this2 International Journal of Peptides
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Figure 1: Biodistribution of cramol in rats.
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Figure 2: Biodistribution %dose/organ versus organ.
solution was incubated with 100µCi (approximately 300µL)
of technetium-99m (IPEN/CNEN) for other 10 minutes in
order to label the cramol 1,4 (here just called cramol) with
Tc-99m.
In order to characterize the labeled cramol, thin-layer
chromatography (TLC) was made using paper Whatman
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Figure 3: Biodistribution %gram/tissue versus organ.
Table 1: Ascending chromatographs of the 99mTc-cramol compar-
ing to free pertechnetate (Na99mTcO4
−).
Solvent Bottom (%) Top (%)
99mTc-cramol Acetone 89.4 10.6
Na99mTcO4
− Acetone 0.3 99.7
no. 1. The TLC was performed using 2µL of a labeled sample
in acetone (Proquimios) as a mobile phase. The radioactivity
ofthestripswasveriﬁedinagammacounter(Packard,Cobra
II) as described in Table 1.
2.2.Biodistribution. Thebiodistributionwasmadeusingone
male Wistar rat. In this direction, the Institutional Review
Board and the Animal Ethics Committee approved the
study protocol for this study. The labeled samples (3,7MBq/
0,2mL) were administered after the catheterization of the
jugular vein. Planar images were obtained 1 hour after in-
jection at a Millennium Gamma Camera (GE Healthcare,
Cleveland, USA). Counts were acquired for 5min in a 15%
window centered at 140KeV (Figure 1). Then, animals were
sacriﬁced, their were organs removed and weighted, and
the radioactivity uptake was counted in a gamma counter
(Packard-Cobra II). Results were expressed as the percentage
of injected dose per organ and percent of injected dose per
gram of tissue (Table 2, Figures 2 and 3).
3. Results and Discussion
3.1. Whatman no. 1 Chromatography. Results are shown in
Table 1.
In this case, the results showed that the acetone can
be used for this purpose. In a triplicate test, all the results
were very close. The free pertechnetate was eluted to the
top of the chromatograms, and the cramol stayed in the
bottom.Moreover,theresultsobservedinthechromatogram
elucidated the question about the eﬃcacy of the labeling
process, corroborating that the cramol was eﬃciently labeled
with Tc-99m.International Journal of Peptides 3
Table 2: Biodistribution of the labeled samples in rat.
Organs %dose/organ %gram/tissue
Heart 2,98 1,78
Right lung 2,65 2,93
Left lung 3,58 2,88
Liver 50,82 4,17
Spleen 4,28 3,69
Stomach 1,44 0,38
Intestine 15,38 23,30
Right kidney 14,83 8,23
Left kidney 3,77 2,35
Blood 0,27 0,27
3.2. Biodistribution Studies. The results of the labeled sample
are as shown below.
99mTc-Cramolscintigraphy1hafterinjectionshowsliver,
kidneys, and bladder. A: anterior view. B: posterior view.
As we can see, the great part of the lectin was processed
by the liver. This is absolutely normal especially for injectable
drugs, since almost all the drugs are ﬁrst processed by the
hepatic system (Figure 2). Otherwise, when dissecting, weig-
hting and counting the organs, a suspicious data appeared.
Figure 3 showed an abnormal accumulation of the lectin in
the bowel. As a protein, we were expecting that its clearance
would be made by the kidney, and in fact, it occurred.
However, the rate between the bowel and the kidney is over
the double. In this case, the clearance time would be reduced
and the reabsorption of the drug could be facilitated by the
microvilli of the bowel. In this case a dosage error could
o c c u ro re v e nat o x i cr e a c t i o nd u ei t sa c c u m u l a t i o ni nt h e
bowel. In both cases, further studies should be made to
clarify this mechanism and the relevance of that information
in a developed drug based on lectin similar to the cramol 1,4.
It is interesting to notice, analyzing both Figures 1 and 2, that
the lectin cannot pass the hematoencephalic barrier. And in
this case, the lectin does not represent a risk for the brain
function.
4. Conclusion
The radiolabeling of the cramol showed that this lectin has
an uncommon behavior specially related to the clearance
mechanism that we believe must be more studied. It also
showed that the nuclear technique can be very helpful for
the development of drugs and medicines. The results help to
elucidate that the lectin cannot cross the hematoencephalic
barrier.
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